Search

everythinglearnresearchcommunity

for

Search:↓

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

RU58841, an androgen receptor blocker, significantly increased hair density, thickness, and length in monkeys when applied topically daily for several months.

Combining RU58841 and minoxidil significantly increases hair growth.

Early hormones shape sex-specific differences in rat glands.

New compounds with carborane showed anti-androgen effects similar to flutamide.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Cannabinoid receptor-1 signaling is essential for the survival and growth of human hair follicle stem cells.

Blocking the mineralocorticoid receptor can help treat skin thinning caused by steroids.

Flutamide improves female hair loss when other treatments fail, but may cause liver toxicity.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

Melatonin helped some Pomeranian dogs regrow hair, but it wasn't linked to estrogen receptors.

Chemicals called 4-(alkylthio)- and 4-(arylthio)-benzonitrile derivatives can potentially reduce oil production on skin, which could help treat conditions like acne and hair loss.

Certain histamine receptors (H2R, H3R, H4R) have unique roles in treating skin diseases, with H2R helping with chronic urticaria and other conditions, H3R providing pain relief and allergy benefits, and H4R reducing inflammation and itchiness.

Testosterone reduces knee flexibility by affecting relaxin receptors.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

Blocking Wnt/β-catenin signaling with EGF receptor is necessary for proper hair growth.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Cheap treatments for excessive hair growth in women can improve symptoms by 35-40% after one year.

Hormonal treatments effectively manage acne in some women, especially with specific hormonal issues.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

New treatments for chronic central serous chorioretinopathy show promise in preventing permanent vision loss.

Plant extracts may help treat hormone-related hair loss.

Anti-androgens are effective for female acne but less so for male-pattern hair loss, with side effects similar to birth control pills.

Some medications can cause reversible hair loss by affecting hair growth cycles.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.